If we go for discovery we try to inhibit what's going on or more regulatory body,
that's the FDA Product Liability if we're talking about medical malpractice.
If we're trying to talk about distributing these different technologies,
sort of typical need where the hospital needs to be certified,
be able to expand it's hospital beds would be critical.
Cost Containment and tech assessments work for same.
So is convergence coming between these two industries?
Basically I think convergence actually is quite likely.
It's the same regulators, in some cases they actually share staffs,
they soon have the same insurance revenues
in the sense of private insurance revenues and risk-based insurance revenues.
Medical devices are starting to look at those metabolizing
threshold what's the drug route extend.
And if drugs need devices for success then that could actually take it even further.
And finally Pharma R&D pipeline has some issues but
device enabled drugs and vice versa could provide a new product line.